ecopa -> About Us -> 7th-ecopa-annual-workshop-2007-presentations

7th-ecopa-annual-workshop-2007-presentations

“Report on eSI, Scientific Plan, 7th Framework Program”
Jose Castell, Vice-president ecopa, ES
PDF: download this presentation (1.8 MB)

“Testing Barriers and Transports: New Basis”
Romeo Cecchelli
PDF: download this presentation (2.7 MB)

“ecopa Budget”
Bernward Garthoff, Treasurer of ecopa
PDF: download this presentation (50 kb)

“Test Requirements of REACH on the Long term vs. Basis of New Methodology”
Bernward Garthoff, Treasurer of ecopa, Bayer AG, Leverkusen, D
PDF: download this presentation (290 kb)

“REACH and current alternative methodological approaches in (pre)validation”
Thomas Hartung & ECVAM Team, Institute for Health and Consumer Protection (IHCP), Ispra (Va), Italy
PDF: download this presentation (424 kb)

“REACH & EPAA: The way to innovate by dual partnership?”
Colin Humphris
PDF: download this presentation (64 kb)

“The Innovative Medicines Initiative: Implications for the Development of 3R-Alternatives”
C. Ian Ragan, European Scientfic Affairs, Ei Lilly and EFPIA Research Directors Group
PDF: download this presentation (264 kb)

“Outcome of the 6th FP Projects, help for REACH?”
Vera Rogiers, Chair of ecopa, Dept. of Toxicology, Vrije Universiteit Brussel, BE
PDF: download this presentation (224 kb)

“Initiatives taken and further acitvities”
Vera Rogiers, Chair of ecopa, Dept. of Toxicology, Vrije Universiteit Brussel, BE
PDF: download this presentation (62 kb)

“REACH and epaa: the way to innovate by dual Partnership? The view from outside: Academia”
H. Seibert, Institute of Toxicology and Pharmacology for Natural Scientist, University Medical School Schleswig-Holstein, Campus Kiel, Germany
PDF: download this presentation (1.3 MB)

“Does Norway need ecopa? Do we need a National Consensus Platform in Norway? What are we doing in Norway?”
Adrian Smith, Norwegian School of Veterinary Science
PDF: download this presentation (660 kb)

“REACH and alternative testing: the REACH information requirements and the perspectives to use alternatives to animal experimentation”
Katinka van der Jagt, DG ENTR / G1 – REACH
PDF: download this presentation (167 kb)

“Partnership”
Jan van der Valk
PDF: download this presentation (76 kb)

“Development of a custom-made microarray as an alternative tool for screening of endrocine disruptors”
Caroline Vanparys, Marleen Maras, Karlijn van der Ven, Johan Robbens, Ronny Blust, Wim de Coen, University of Antwerp, Belgium
PDF: download this presentation (1.1 MB)

“Impact of REACH on Animal Use”
Simon Webb
PDF: download this presentation (1.8 MB)

“Characterization of a renal cell model by gene expression analysis”
Christina Weiland, Molecular and Special Toxicology, Bayer Healthcare AG
PDF: download this presentation (448 kb)